Cover Image
市場調查報告書

腦缺血:全球臨床實驗趨勢

Brain Ischemia Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 239403
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
Back to Top
腦缺血:全球臨床實驗趨勢 Brain Ischemia Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 74 Pages
簡介

本報告提供腦缺血治療藥的臨床試驗相關基本資料和數據,提供您各地區,各階段,各進展狀況的實施數量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關的臨床試驗之進展,有潛力的藥劑比較等資訊。

簡介

  • 腦缺血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主5國的臨床實驗數量
    • 歐洲主5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦缺血的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦缺血的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

腦缺血治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • C. H. Boehringer Sohn AG & Co. KG
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • Prolong Pharmaceuticals
    • NoNO, Inc.
    • 三菱化學控股
    • GlaxoSmithKline plc
    • Edge Therapeutics, Inc.
    • D-Pharm Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Asan Medical Center
    • China Medical University Hospital
    • Gachon University Gil Hospital
    • UMC Utrecht Holding BV
    • University of Southern California
    • Academic Medical Center
    • Auckland City Hospital
    • Centre hospitalier de l'Universite de Montreal
    • Centre Hospitalier Universitaire de Poitiers
    • Centre Hospitalier Universitaire de Saint Etienne

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2616CTIDB

GlobalData's clinical trial report, "Brain Ischemia Global Clinical Trials Review, H1, 2015" provides data on the Brain Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Brain Ischemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Brain Ischemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Brain Ischemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Prolong Pharmaceuticals
      • Clinical Trial Overview of Prolong Pharmaceuticals
      • NoNO, Inc.
      • Clinical Trial Overview of NoNO, Inc.
      • Mitsubishi Chemical Holdings Corporation
      • Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Edge Therapeutics, Inc.
      • Clinical Trial Overview of Edge Therapeutics, Inc.
      • D-Pharm Ltd.
      • Clinical Trial Overview of D-Pharm Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • China Medical University Hospital
      • Clinical Trial Overview of China Medical University Hospital
      • Gachon University Gil Hospital
      • Clinical Trial Overview of Gachon University Gil Hospital
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • University of Southern California
      • Clinical Trial Overview of University of Southern California
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Auckland City Hospital
      • Clinical Trial Overview of Auckland City Hospital
      • Centre hospitalier de l'Universite de Montreal
      • Clinical Trial Overview of Centre hospitalier de l'Universite de Montreal
      • Centre Hospitalier Universitaire de Poitiers
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Poitiers
      • Centre Hospitalier Universitaire de Saint Etienne
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Brain Ischemia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Brain Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Brain Ischemia Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolong Pharmaceuticals, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by D-Pharm Ltd., 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gachon University Gil Hospital, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland City Hospital, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre hospitalier de l'Universite de Montreal, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Poitiers, 2015*
  • Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2015*

List of Figures

  • Brain Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top